Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer — Stella

Home/Colorectal Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Colorectal Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Finland

Helsinki University Central Hospital, Helsinki, Uusimaa

Tampere University Hospital, Tampere

Key details

Sponsor

Helsinki University Central Hospital

Enrollment target

~93 participants

Started

December 2021

Primary completion

August 2028

Age range

18 Years – 100 Years

Last updated March 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.